Insomnia and suicidal ideation in nonaffective psychosis.
Journal
Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
12
12
2017
pubmed:
9
11
2018
medline:
31
3
2020
entrez:
9
11
2018
Statut:
ppublish
Résumé
Insomnia is a common symptom in the clinical course of schizophrenia. There is a robust association between insomnia and suicidality in other psychiatric disorders. Two previous studies found associations between insomnia and suicide attempt or completed suicide in patients with schizophrenia. We hypothesized that greater insomnia would be associated with greater levels of suicidal ideation in patients with schizophrenia and other nonaffective psychoses. We recruited 108 inpatients and outpatients age 18-65 between July 2010 and July 2016 with DSM-IV nonaffective psychosis (schizophrenia, schizoaffective disorder, or schizophreniform disorder). We investigated relationships between current insomnia (Insomnia Severity Index [ISI]), suicidal ideation over the past week, and lifetime history of suicide attempt (Beck Scale for Suicide Ideation [BSS]) in regression analyses. After controlling for potential confounders, insomnia was a significant indicator of suicidal ideation (β = 0.27, p = 0.032). Insomnia was also a significant indicator of a high BSS score (≥16; OR = 1.14, 95% CI: 1.01-1.28, p = 0.029). Furthermore, participants with severe insomnia were almost 15 times more likely to have a lifetime history suicide attempt than participants without current insomnia (OR = 14.8, 95% CI: 1.4-157, p = 0.025). Insomnia was also an indicator of greater PANSS total (β = 0.33, p = 0.001), positive subscale (β = 0.32, p = 0.002), and general subscale (β = 0.40, p < 0.001) scores. Insomnia is associated with suicidal ideation, lifetime suicide attempt, and greater psychopathology in patients with schizophrenia. Our findings suggest that formal assessment of insomnia may be germane to the clinical care of patients with schizophrenia as a marker of suicide risk and symptom severity.
Identifiants
pubmed: 30407600
pii: 5165662
doi: 10.1093/sleep/zsy215
pmc: PMC6369728
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIMH NIH HHS
ID : K23 MH098014
Pays : United States
Références
Schizophr Res. 2009 Jul;112(1-3):80-5
pubmed: 19410429
J Psychopharmacol. 2010 Nov;24(4 Suppl):91-118
pubmed: 20923924
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:209-16
pubmed: 23318689
J Clin Psychiatry. 2003 Jun;64(6):663-7
pubmed: 12823080
Ann Behav Med. 2011 Oct;42(2):141-52
pubmed: 21604067
Schizophr Bull. 2018 Apr 6;44(3):662-671
pubmed: 28981834
Behav Cogn Psychother. 2016 May;44(3):273-87
pubmed: 26751571
Clin Schizophr Relat Psychoses. 2014 Jan;7(4):223-30
pubmed: 23428789
Psychosis. 2017 Apr 3;9(2):129-139
pubmed: 28670337
Sleep Med Rev. 2017 Apr;32:69-84
pubmed: 27061476
Psychiatry Res. 2017 Dec;258:449-456
pubmed: 28886903
Lancet Psychiatry. 2015 Nov;2(11):975-83
pubmed: 26363701
Schizophr Res. 2015 Oct;168(1-2):50-5
pubmed: 26220853
Eur Neuropsychopharmacol. 2015 Oct;25(10):1824-31
pubmed: 26032768
Biol Psychiatry. 2015 Jul 1;78(1):28-37
pubmed: 25541493
Schizophr Bull. 2001;27(3):497-502
pubmed: 11596850
Biol Psychiatry. 2016 Jul 1;80(1):40-52
pubmed: 26140821
Syst Rev. 2014 Feb 25;3:18
pubmed: 24568642
Br J Psychiatry. 2012 Apr;200(4):308-16
pubmed: 22194182
Mol Psychiatry. 2016 Dec;21(12):1696-1709
pubmed: 26903267
Eur Neuropsychopharmacol. 2017 Sep;27(9):885-891
pubmed: 28663123
Neuropsychiatr Dis Treat. 2013;9:941-6
pubmed: 23882141
Sleep Med. 2012 Sep;13(8):1021-7
pubmed: 22841033
Front Psychol. 2015 Jul 14;6:990
pubmed: 26236265
Schizophr Res. 2014 Dec;160(1-3):180-5
pubmed: 25454802
Schizophr Res. 2017 Nov;189:37-42
pubmed: 28169087
Addiction. 2003 Jan;98(1):111-8
pubmed: 12492762
Schizophr Res. 2012 Sep;140(1-3):232-6
pubmed: 22796150
Compr Psychiatry. 1994 Sep-Oct;35(5):341-8
pubmed: 7995025
J Clin Sleep Med. 2014 Dec 15;10(12):1317-23
pubmed: 25325605
Curr Psychiatry Rep. 2013 Sep;15(9):389
pubmed: 23949486
Sleep Med Rev. 2017 Feb;31:25-38
pubmed: 26920092
Psychiatry Res. 2009 May 30;167(3):251-7
pubmed: 19395048
Brain Behav Immun. 2009 Oct;23(7):887-97
pubmed: 19389469
Compr Psychiatry. 2011 Sep-Oct;52(5):479-85
pubmed: 21185016
J Psychopharmacol. 2018 Apr;32(4):482-488
pubmed: 29552947
JAMA Psychiatry. 2017 Dec 1;74(12):1226-1233
pubmed: 29094161
Schizophr Res. 2018 Mar;193:204-208
pubmed: 28711475
Indian J Psychiatry. 2013 Jul;55(3):283-6
pubmed: 24082251
Neurosci Biobehav Rev. 2014 Sep;45:233-45
pubmed: 24971825
Schizophr Res. 2018 Feb;192:16-29
pubmed: 28416092
Eur Psychiatry. 2017 Jul;44:164-172
pubmed: 28645055
Sleep. 2016 Jun 01;39(6):1275-82
pubmed: 27091530
Schizophr Res. 2016 Jul;174(1-3):17-23
pubmed: 27132483
Psychiatry Res. 2016 Jul 30;241:141-6
pubmed: 27173659
Sleep Med. 2010 Oct;11(9):822-7
pubmed: 20478741
Am J Psychiatry. 2013 Nov;170(11):1263-74
pubmed: 23846857
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Am J Prev Med. 1998 May;14(4):245-58
pubmed: 9635069
Psychiatry Res. 1988 Jan;23(1):99-110
pubmed: 3363019
Eur Arch Psychiatry Clin Neurosci. 2000;250(6):304-10
pubmed: 11153965
Compr Psychiatry. 2002 Sep-Oct;43(5):393-6
pubmed: 12216015
Psychiatry Res. 2017 Aug;254:80-84
pubmed: 28456026
CNS Drugs. 2008;22(11):939-62
pubmed: 18840034
Psychiatry Res. 2016 Dec 30;246:154-160
pubmed: 27697656
Psychiatry Res. 2017 Sep;255:8-12
pubmed: 28505469
Schizophr Res. 2015 Dec;169(1-3):30-35
pubmed: 26475215
J Clin Psychol. 1988 Jul;44(4):499-505
pubmed: 3170753
Psychosom Med. 2007 Nov;69(8):756-61
pubmed: 17942834